I had a patient last month who did everything right. 60 lbs down on tirzepatide. A1c from 6.4 to 5.3.
She told me: "I'm scared my body is just waiting to take it all back."
Six new papers just proved her right.
Weight regain isn't moral failure. It's cellular memory.
Brian Tracy on how to change your life:
"Get up early enough to read for 30-60 minutes in something that is motivational, something that is inspirational, something that is educational. Something that uplifts your mind, what we call mental protein."
HbA1c is not used for diagnosing gestational diabetes 🤔‼️
Why ?
Because in a pregnant individual the A1c levels you are going to get NOW, i.e. at screening time (2nd trimester ~ 24th week gestation) are reflective of almost 10-12 week ago.
It does not reflect CURRENT ongoing effects from HPL hormone, progesterone and cortisol — the notorious trio to induce insulin resistance and gestational DM in an effort to provide more glucose to baby 👶🏻🍼
So what should i use that has higher sensitivity and specificity in this case ?
Answer is — oral glucose tolerance test
OGTT at 24-28 weeks is recommended as the best test to rule in or out gestational diabetes
Get the patient come in fasting — give 75 grams of PO glucose and then, measure BSG 1 and 2 hr mark, and diagnoses is made if any if the following happens :
— Fasting BSG > 92
— 1 hr > 180
— 2 hr > 153
#MedTwitter #MedX #Endocrinology
New ACC/AHA Lipid Guidelines 2026 — Practice-Changing Insights:At a glance..
📌 Core Philosophy
“Lower LDL-C, earlier and for longer → better lifetime ASCVD reduction.”
🔬 1. Start Early – Think Lifetime Risk
Lipid screening should begin at ≥19 years, with repeat every 5 years or earlier in high-risk individuals.
Statin therapy can be initiated as early as 30 years if LDL-C ≥160 mg/dL, strong family history, or high 30-year risk—even if 10-year risk is low.
🎙️Key shift: Move from “10-year risk” to lifetime cumulative exposure model
🧮 2. PREVENT Risk Calculator Replaces PCE
New AHA PREVENT tool improves ASCVD risk prediction and starts risk estimation from age 30.
Includes 30-year risk estimation, crucial for younger patients.
📊 3. Recalibrated Risk Categories
Low: <3%
Borderline: 3–5%
Intermediate: 5–10%
High: ≥10%
👉 Clinical implication: Statins now justified at lower thresholds (≥5%)
🎯 4. LDL-C Targets Are Back
<100 mg/dL → Low/intermediate risk
<70 mg/dL → High risk
<55 mg/dL → Established ASCVD
👉 Shift: From % reduction → absolute target-driven therapy
🧬 5. Universal Lp(a) Testing
One-time Lp(a) measurement for ALL patients is now recommended.
≥125 nmol/L → ↑ ASCVD risk
≥250 nmol/L → ~2× risk
≥430 nmol/L → ~4× risk
👉 Intensify LDL lowering even if Lp(a) cannot yet be directly treated
🧪 6. ApoB & CAC — Precision Risk Tools
ApoB reflects total atherogenic particle burden and helps detect residual risk.
CAC score acts as “tiebreaker” in borderline/intermediate risk.
⚠️ 7. Expanded Risk Enhancers
Now includes:
PCOS, early menopause, adverse pregnancy outcomes
South Asian and Filipino ethnicity
CKM syndrome, inflammation markers
👉 Clinical message: Take detailed reproductive & ethnic history seriously
🩺 8. Special Populations – Stronger Statin Mandate
All patients (40–75 yrs) with:
CKD stage 3–4
HIV infection
→ Should receive statins irrespective of LDL-C
🍔 9. Triglycerides – Lifestyle First
Statins remain foundational even in hypertriglyceridemia.
Refer to dietitians if TG ≥150–1000 mg/dL with CKM features.
💊 10. Supplements – Clear Negative Recommendation
Non-prescription supplements (e.g., fish oil) are NOT recommended for ASCVD risk reduction due to lack of benefit.
🔥 CME INDIA Take-Home Messages
Atherosclerosis begins early → intervene early
LDL exposure = cumulative toxin → duration matters as much as level
Lp(a) is now a universal risk marker, not optional
Risk assessment is shifting from short-term to lifetime biology
Precision lipidology = LDL-C + ApoB + Lp(a) + CAC
🏷️
“From numbers to lifetime exposure: Lipidology has entered the era of precision prevention.”
https://t.co/HU2Fcucaf3
@Sylvia147225911 Here is an early access free copy of my new parable, The Sages of the Hidden Road: https://t.co/RviiEBLv7d
If you do enjoy the read, I would be incredibly grateful if you could share your thoughts via a review on Goodreads and Amazon (on 11 May).
@Zuliovna@RuthSummie Would you like to share some few words about the novel ...your honest thoughts ...even by private msg ...i would like to hear from you.